M. Nitschke, Gunnar Krüger, H. Bruhn
Nov 1, 2001
Citations
6
Influential Citations
313
Citations
Quality indicators
Journal
Movement Disorders
Abstract
This open study assessed the ability of rivastigmine to treat the neuropsychiatric complications of advanced Parkinson's disease. In a group of 12 patients, hallucinations, sleep disturbance, and carer distress were all improved and cognitive performance significantly enhanced by the drug. © 2001 Movement Disorder Society.